Targeting the Non-Canonical Phosphoinositide Kinases in P53 Mutant Breast Cancer

Abstract

The ultimate goal and the overall impact of this project are to characterize PI5P4Ks as a novel liability for breast tumors with TP53 mutations in order to define opportunities for therapeutic intervention for breast cancer patients with these mutations, which currently lack targeted therapy.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Sep 01, 2020
Accession Number
AD1118639

Entities

People

  • Brooke M Emerling

Organizations

  • Sanford Burnham Prebys Medical Discovery Institute

Tags

DTIC Thesaurus Topics

  • Abstracts
  • Autophagy
  • Biomedical Research
  • Breast Cancer
  • California
  • Cancer
  • Cell Line
  • Cell Physiological Processes
  • Cells
  • Department Of Defense
  • Education
  • Electronic Mail
  • Homeostasis
  • Lethality
  • Lysosomes
  • Metabolism
  • Mutations
  • Neoplasms
  • Patent Applications
  • Professional Development
  • Scientific Research
  • Standards
  • Students
  • Targeting
  • Therapy
  • Training

Readers

  • Molecular Biology and Genetics
  • Oncology